Table 1 Number of samples contributing to each class and omic type for each dataset
From: Inferring pathway dysregulation in cancers from multiple types of omic data
Analysis | Class 1 | Class 2 | Somatic mutation | RNA-Seq | CNV | Microarray |
|---|---|---|---|---|---|---|
p53 mutation status | 17 | 33 | - | - | - | 50 |
Wild-type | p53-mutated | |||||
Gender | 15 | 17 | - | - | - | 32 |
Male | Female | |||||
RAS mutation status (TCGA LUAD) | 66 | 161 | - | 169 | - | - |
Wild-type | RAS-mutated | |||||
HER2 analysis (TCGA breast) | 58 | 489 | 506 | 508 | 308 | 519 |
HER2 + | Other breast | |||||
USC analysis (TCGA endometrial) | 53 USC | 307 UEC | 244 | 323 | 353 | - |